SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

25 May 2023 Evaluate
The sales moved up 28.10% to Rs. 4311.96 millions for the March 2023 quarter as compared to Rs. 3366.07 millions during the year-ago period.Net Profit for the quarter ended March 2023 zoomed to 158.98% from Rs. 143.80 millions to Rs. 372.41  millions.The company reported a good operating profit of 640.26 millions compared to 288.09 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 4311.96 3366.07 28.10 17770.32 15189.65 16.99 17770.32 15189.65 16.99
Other Income 101.48 116.01 -12.52 539.12 787.34 -31.53 539.12 787.34 -31.53
PBIDT 640.26 288.09 122.24 3084.87 3255.80 -5.25 3084.87 3255.80 -5.25
Interest 11.47 6.88 66.72 40.39 30.48 32.51 40.39 30.48 32.51
PBDT 628.79 281.21 123.60 3044.48 3225.32 -5.61 3044.48 3225.32 -5.61
Depreciation 96.90 91.62 5.76 387.58 370.81 4.52 387.58 370.81 4.52
PBT 531.89 189.59 180.55 2656.90 2854.51 -6.92 2656.90 2854.51 -6.92
TAX 159.48 45.79 248.29 647.25 658.15 -1.66 647.25 658.15 -1.66
Deferred Tax 11.48 11.79 -2.63 -42.75 -21.85 95.65 -42.75 -21.85 95.65
PAT 372.41 143.80 158.98 2009.65 2196.36 -8.50 2009.65 2196.36 -8.50
Equity 165.91 168.81 -1.72 165.91 168.81 -1.72 165.91 168.81 -1.72
PBIDTM(%) 14.85 8.56 73.49 17.36 21.43 -19.01 17.36 21.43 -19.01

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×